+39 02 610346.1 - info@newron.com

Latest press releases

  • 14Sep
    Newron reports half-year 2017 results

     

  • 11Jul
    XADAGO® (SAFINAMIDE) NOW AVAILABLE IN THE U.S. FOR PARKINSON’S DISEASE PATIENTS

     

  • 17May
    Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients Under 13 Years of Age

     

  • 12May
    Newron Receives EUR11.3m Milestone Payments for US Approval of Xadago® (safinamide)

     

  • 11Apr
    Valeo Pharma and Zambon form partnership for Parkinson’s disease treatment Xadago® (safinamide) in Canada

  • 10Apr
    ZAMBON LAUNCHES XADAGO® (safinamide) IN PORTUGAL For patients With mid- to late-stage Parkinson’s Disease

     

View All

Newron share price

Events

  • 27Nov
    German Equity Forum 2017

    Nov, 27-29, 2017 - Frankfurt

  • 15Nov
    Jefferies 2017 London Healthcare Conference

    Nov, 15-16, 2017 - Waldorf Hilton, London

  • 20Sep
    Investora 2017

    Sept. 20-21, 2017 - Zurich, CH

View Event Calendar